Neurothrombectomy Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F By Product (Clot Retrievers, Aspiration Devices, Vascular Snares, Others) By End-User (Hospitals, Ambulatory Surgical Centers, Others), By Region, and Competition

Industry : Healthcare
Pages : NA
Published Date : NA

Customization Enquiry

Buy Now

Single User Licence

$4900

Multi-User Licence

$5900

Custom Research Licence

$8900

Summary

Request Sample

Report Description

Global neurothrombectomy devices market is expected to grow at a formidable rate during the forecast period. The increasing occurrence of ischemic stroke across the world is the major driver for the forecast period. A surge in awareness among the people regarding different cardiovascular disorders is enabling them to take effective treatment at the right time which is boosting the demand for neurothrombectomy devices. The rise in the geriatric population which is susceptible to various kinds of strokes, thereby supporting the market growth. A large number of people die before reaching to the hospital when are affected by the occurrence of a brain hemorrhage. Neurothrombectomy devices can improve the effectiveness of the disease without adversely affecting intracranial hemorrhage.

Devices for neurothrombectomy are essential in the treatment of ischemic stroke, which affects older persons often. Adults older than 40 have been found to have an increased risk of stroke as a result of modern lifestyle, stress, and eating choices. A stroke episode leaves over 65% of patients in need of physical support or help, making it the main cause of disability among elderly people. The WHO estimates that 15 million people worldwide get a stroke each year. The neurothrombectomy method is the most preferred treatment for acute ischemic stroke since it enhances functional results and reduces patient mortality, increasing market growth during the forecast period.

Demand for Minimally Invasive Surgeries along with the Prevalence of Acute Ischemic Stroke

The demand for minimally invasive procedures combined with growing awareness of acute ischemic stroke has led to an increase in the deployment of these devices on a global scale. Minimally invasive surgical procedures and devices that facilitate faster recovery, leave no scar of incisor on the body, shorter hospital stay, and are cost-effective in nature which is the major reason for the high demand of neurothrombectomy devices across the world. As per the American Stroke Association revealed that more than 690,000 ischemic strokes are reported each year in the United States. Additionally, a rise in market participants' investments in the research and development of cutting-edge equipment and the availability of reimbursement policies to cover treatment expenses are some of the factors contributing to the market's expansion.

Download Free Sample Report

Rising Government Initiatives

The government has launched a number of programs around the world to prevent strokes. The U.S. Centers for Disease Control and Prevention (CDC) launched the Well-integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) programme in three states—North Cartolina, Massachusetts, and Arizona—to reduce the risk of stroke and heart diseases in women by encouraging a heart-healthy lifestyle. These initiatives aim to raise awareness of heart illnesses and other chronic disorders among low-income, uninsured women and other people in their 40s to 64s. Due to such awareness campaigns, from 2008 to 2013, over 91% of women who suffered a stroke received quality care. In addition, the World Stroke Organization launched the Global Stroke Bill of Rights campaign in 2014 for those who were experiencing a stroke. This initiative enables patients to access quality care. Hence, Government Initiatives drive the growth of the market during the forecast period.

Market Segmentation

Global neurothrombectomy devices market is segmented into product, end-user, regional distribution, and company. By Product the market is divided into Clot Retrievers, Aspiration Device, Vascular Snares, Others. By End-User the market is divided into Hospitals, Ambulatory Surgical Centers, Others

Market Players

The major players operating in the global neurothrombectomy devices market are Abbott Laboratories Inc., Medtronic Plc., Stryker Corporation, Acandis GmbH, Phenox GmbH, Penumbra Inc., Vesalio, LLC, Siemens Healthineers AG, Inari Medical Inc., Johnson & Johnson, among others.

Attribute	Details
Base Year	2022
Historical Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million and CAGR for 2018-2022 and 2023E-2028F
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Product End User
Regional scope	North America; Europe; Asia Pacific; South America; Middle East & Africa
Country scope	United States, Mexico, Canada, China, India, Japan, Australia; South Korea, Germany, France, United Kingdom, Italy, Spain, South Africa, UAE, Saudi Arabia, Kuwait, Brazil, Argentina, Colombia.
Key companies profiled	Abbott Laboratories Inc., Medtronic Plc., Stryker Corporation, Acandis GmbH, Phenox GmbH, Penumbra Inc., Vesalio, LLC, Siemens Healthineers AG, Inari Medical Inc., Johnson & Johnson.
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global neurothrombectomy devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

· Neurothrombectomy Devices Market, By Product:

Clot Retrievers
Aspiration Device
Vascular Snares
Others

Neurothrombectomy Devices Market, By End-User:

Hospitals
Ambulatory Surgical Centers
Others

Neurothrombectomy Devices Market, By Region:

North America

United States
Mexico
Canada

Europe

France
United Kingdom
Italy
Germany
Spain

Asia-Pacific

China
India
Japan
Australia

§ South Korea

o Middle East & Africa

South Africa
UAE
Saudi Arabia
Kuwait

South America

§ Brazil

§ Argentina

§ Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global neurothrombectomy devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Neurothrombectomy Devices market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Neurothrombectomy Devices Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product (Clot Retrievers, Aspiration Devices, Vascular Snares, Others)

5.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Others)

5.2.3. By Region

5.2.4. By Company (2022)

5.3. Market Map

6. North America Neurothrombectomy Devices Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product (Clot Retrievers, Aspiration Devices, Vascular Snares)

6.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Others)

6.2.3. By Country

6.3. North America: Country Analysis

6.3.1. United States Neurothrombectomy Devices Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product

6.3.1.2.2. By End User

6.3.2. Mexico Neurothrombectomy Devices Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product

6.3.2.2.2. By End User

6.3.3. Canada Neurothrombectomy Devices Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product

6.3.3.2.2. By End User

7. Europe Neurothrombectomy Devices Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product (Clot Retrievers, Aspiration Devices, Vascular Snares)

7.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Others)

7.2.3. By Country

7.3. Europe: Country Analysis

7.3.1. France Neurothrombectomy Devices Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product

7.3.1.2.2. By End User

7.3.2. United Kingdom Neurothrombectomy Devices Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product

7.3.2.2.2. By End User

7.3.3. Italy Neurothrombectomy Devices Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Product

7.3.3.2.2. By End User

7.3.4. Germany Neurothrombectomy Devices Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product

7.3.4.2.2. By End User

7.3.5. Spain Neurothrombectomy Devices Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product

7.3.5.2.2. By End User

8. Asia-Pacific Neurothrombectomy Devices Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product (Clot Retrievers, Aspiration Devices, Vascular Snares)

8.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Others)

8.2.3. By Country

8.2.4. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Neurothrombectomy Devices Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product

8.3.1.2.2. By End User

8.3.2. India Neurothrombectomy Devices Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product

8.3.2.2.2. By End User

8.3.3. Japan Neurothrombectomy Devices Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product

8.3.3.2.2. By End User

8.3.4. Australia Neurothrombectomy Devices Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product

8.3.4.2.2. By End User

8.3.5. South Korea Neurothrombectomy Devices Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product

8.3.5.2.2. By End User

9. South America Neurothrombectomy Devices Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product (Clot Retrievers, Aspiration Devices, Vascular Snares)

9.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Others)

9.2.3. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Neurothrombectomy Devices Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product

9.3.1.2.2. By End User

9.3.2. Argentina Neurothrombectomy Devices Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product

9.3.2.2.2. By End User

9.3.3. Colombia Neurothrombectomy Devices Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product

9.3.3.2.2. By End User

10. Middle East and Africa Neurothrombectomy Devices Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product (Clot Retrievers, Aspiration Devices, Vascular Snares)

10.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Others)

10.2.3. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Neurothrombectomy Devices Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product

10.3.1.2.2. By End User

10.3.2. UAE Neurothrombectomy Devices Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product

10.3.2.2.2. By End User

10.3.3. Saudi Arabia Neurothrombectomy Devices Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product

10.3.3.2.2. By End User

10.3.4. Kuwait Neurothrombectomy Devices Market Outlook

10.3.4.1. Market Size & Forecast

10.3.4.1.1. By Value

10.3.4.2. Market Share & Forecast

10.3.4.2.1. By Product

10.3.4.2.2. By End User

11. Market Dynamics

11.1. Drivers

11.1.1. Rising Prevalence of Acute Ischemic Heart Strokes

11.1.2. Increasing Demand of Minimally Invasive Surgeries

11.2. Challenges

11.2.1. High Price of Neurothrombectomy Devices

12. Market Trends & Developments

13. Competitive Landscape

13.1. Abbott Laboratories, Inc.

13.1.1. Business Overview

13.1.2. Product Offerings

13.1.3. Recent Developments

13.1.4. Financials (As Reported)

13.1.5. Key Personnel

13.1.6. SWOT Analysis

13.2. Medtronic Plc.

13.3. Stryker Corporation

13.4. Acandis GmbH

13.5. Phenox GmbH

13.6. Penumbra Inc.

13.7. Vesalio, LLC

13.8. Siemens Healthineers AG

13.9. Inari Medical Inc.

13.10. Johnson & Johnson

14. Strategic Recommendations

15. About Us & Disclaimer

Figures and Tables

Frequently asked questions

What major factors drive Global Neurothrombectomy Devices Market growth?

The market is primarily driven by rising rates of acute ischemic stroke on a global basis.

Which companies may dominate the Global Neurothrombectomy Devices Market?

Abbott Laboratories Inc., Medtronic Plc., Stryker Corporation, Acandis GmbH, Phenox GmbH, Penumbra Inc., Vesalio, LLC, Siemens Healthineers AG, Inari Medical Inc., Johnson & Johnson, among others are some of the leading players operating in the global neurothrombectomy devices market.

Which segment is anticipated to dominate the Global Neurothrombectomy Devices Market?

Based on End Use the market is divided into Hospitals, Ambulatory Surgical Centers, and Others. The hospital segment is expected to dominate the market growth during the forecast period owing to the high preference of patients and the presence of advanced facilities along with skilled professionals.

Which region is expected to dominate the growth of Global Neurothrombectomy Devices during the forecast period?

In the regional segment, Europe dominated the Neurothrombectomy Devices market owing to the increasing number of patients suffering from acute ischemic stroke.

Related Reports

Sakshi Bajaal

Business Consultant

Talk To Analyst

Press Release

Clot Retrievers segment to dominate the Global Neurothrombectomy Devices Market till 2026

Jul, 2021

Changing lifestyle and increasing old age population is expected to drive the demand for global neurothrombectomy devices market in the forecast period.